S. Longuemaux et al., Candidate genetic modifiers of individual susceptibility to renal cell carcinoma: A study of polymorphic human xenobiotic-metabolizing enzymes, CANCER RES, 59(12), 1999, pp. 2903-2908
The steady increase in sporadic renal cell carcinoma (RCC) observed in indu
strialized countries supports the notion that certain carcinogens present i
n the environment (tobacco smoke, drugs, pollutants, and dietary constituen
ts) may affect the occurrence of RCC. Many of the enzymes dealing with such
environmental factors are polymorphic and mag, therefore, confer variable
susceptibility to RCC. This case-control study was designed to test for an
association between genetic polymorphism of enzymes involved in xenobiotic
metabolism and the risk of sporadic RCC. Genomic DNA was obtained from 173
patients with RCC and 211 controls of Caucasian origin. We used PCR-RFLP to
investigate polymorphism for the most common alleles at two cytochrome-P45
0 mono-oxygenases (CYP1A1 and CYP2D6), one NAD[P]H:quinone oxidoreductase (
HQO1), three glutathione S-transferases (GSTM1, GSTT1, and GSTP1), and one
N-acetyltransferase (NAT2) loci. The CYP1A1 (m) "variant" genotype, which c
ontains at least one copy of the CYP1A1 variant alleles, was found to be as
sociated with a 2.1-fold [95% confidence interval (CI), 1.1-3.9] increase i
n the risk of RCC. There was also a higher risk of RCC for subjects with th
e CYP1A1 (m) variant genotype combined with any of the following genotypes:
GSTT1 (+) "active'' [odds ratio (OR), 2.3; 95% CI, 1.2-4.5], GSTP1 (m) var
iant (OR, 2.4; 95%, CI, 1.0-5.4), or NAT2 (-) "slow acetylator" (OR, 2.5; 9
5% CI, 1.1-5.5). A significant association was also found for the GST,MI (-
) "null" and GSTP1 (m) genotypes combined with either NAT2 (-) (OR, 2.6; 95
% CI, 1.2-5.8) or CYP1A1 (m) (OR, 3.5; 95% CI, 1.1-11.2). The CYP2D6 (-) "p
oor metabolizer' and the NQO1 (-) "defective" genotypes were not clearly as
sociated with a higher risk of RCC. Our data demonstrate for the first time
a significant association between a group of pharmacogenetic polymorphisms
and RCC risk. These positive findings suggest that interindividual variati
on in the metabolic pathways involved in the functionalization and detoxifi
cation of specific xenobiotics is an important susceptibility factor for RC
C in Caucasians.